Advertisement

Digestive Diseases and Sciences

, Volume 27, Issue 9, pp 807–814 | Cite as

Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency

  • Maria Read
  • N. W. Read
  • D. C. Barber
  • H. L. Duthie
Original Articles

Abstract

We have investigated the effect of loperamide (4 mg tds) on the continence to a standard volume of rectally infused saline and anorectal manometry in 26 patients complaing of chronic diarrhea complicated by fecal incontinence and severe urgency. Each patient was treated for one week with loperamide (4 mg tds) and for one week with an identical placebo in a double-blind cross-over trial. Our results showed that as well as its established effects of improving stool consistency and reducing stool weight, frequency and episodes of incontinence and severe urgency, loperamide also significantly improved continence to a standard volume of rectally infused saline. This action was associated with an increase in the maximum basal sphincter pressure, an increase in the rectal volume required to abolish recovery of the rectoanal inhibitory reflex, and a reduction in rectal compliance. These results suggest that loperamide may have a specific action on the anal sphincter, which may aid continence in patients who complain of diarrhea and fecal incontinence.

Keywords

Fecal Incontinence Anal Sphincter Loperamide Chronic Diarrhea Sphincter Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Parks AG: Anorectal incontinence. Proc R Soc Med 68:681–690, 1975PubMedGoogle Scholar
  2. 2.
    Cerulli MA, Nikoomanesh P, Schuster MM: Progress in biofeedback conditioning for fecal incontinence. Gastroenterology 76:742–746, 1979PubMedGoogle Scholar
  3. 3.
    MacLeod JH: Biofeedback in the management of partial anal incontinence. Dis Colon Rectum 22:169–171, 1979PubMedGoogle Scholar
  4. 4.
    Palmer KR, Corbett CL, Holdsworth CD: Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 79:1272–1275, 1980PubMedGoogle Scholar
  5. 5.
    Manning AP, Thompson WG, Heaton KW, Morris AF: Towards positive diagnosis of the irritable bowel. Br Med J 2(6138):653–654, 1978PubMedGoogle Scholar
  6. 6.
    Koelz HR, Brandli HH, Blum AL: Simple perfusion pump for gastrointestinal manometry. Lancet 2(7944):1075, 1975PubMedGoogle Scholar
  7. 7.
    Read NW, Harford WV, Schmulen AC, Read MG, Santa Ana C, Fordtran JS: A clinical study of patients with fecal incontinence and diarrhea. Gastroenterology 76:747–756, 1979PubMedGoogle Scholar
  8. 8.
    Schuster MM, Hendrix TR, Mendeloff AI: The internal anal sphincter response: Manometric studies on its normal physiology, neural pathways and alteration in bowel diseases. J Clin Invest 42:196–207, 1963PubMedGoogle Scholar
  9. 9.
    Pimparkar BD, Tulsky EG, Kalser MH, Bockus HL: Correlation of radioactive and chemical fecal fat determinations in the malabsorption syndrome. I. Studies in normal man and in functional disorders of the gastrointestinal tract. Am J Med 30:910–926, 1961PubMedGoogle Scholar
  10. 10.
    Rendtorff RC, Kashgarian M: Stool patterns of healthy adult males. Dis Colon Rectum 10:222–228, 1967PubMedGoogle Scholar
  11. 11.
    Burkitt DP, Walker ARP, Painter NS: Effect of dietary fibre on stools and transit times and its role in the causation of disease. Lancet 2:1408–1411, 1972PubMedGoogle Scholar
  12. 12.
    Harford WV, Krejs GJ, Santa Ana C, Fordtran JS: Acute effect of diphenoxylate with atropine (Lomotil) in patients with chronic diarrhea and fecal incontinence. Gastroenterology 78:440–443, 1980PubMedGoogle Scholar
  13. 13.
    Jaffe JH, Martin WR: Narcotic analgesics and antagonists.In The Pharmacological Basis of Therapeutics, LS Goodman, A. Gilman (eds). New York: Macmillan, 1975, p. 235Google Scholar
  14. 14.
    Yagasaki O, Suzuki H, Sohji Y: Effects of loperamide on acetylcholine and prostaglandin release from isolated guinea-pig ileum. Jpn J Pharmacol 28:873–882, 1978PubMedGoogle Scholar
  15. 15.
    Gutierrez JG, Oliai A, Shah A, Chey WY: Studies on the mechanical and electrical activity of the internal anal sphincter in man: Cholinergic control and effects of secretin and CCK. Gastroenterology 68(A51):908, 1975Google Scholar
  16. 16.
    Burleigh DE, D'Mello A, Parks AG: Responses of isolated human internal anal sphincter to drugs and electrical field stimulation. Gastroenterology 77:484–489, 1979PubMedGoogle Scholar
  17. 17.
    McKirdy HC: Effect of loperamide on human isolated internal anal sphincter. Proc Physiol Soc C16:20–21, 1981Google Scholar
  18. 18.
    Niemegeers CJE, McGuire JL, Heykauts JJP, Janssen PAJ: Experimental dissociation between opiate-like and antidiarrhoeal activities of antidiarrhoeal drugs. J Pharmacol Exp Ther 310:327–337, 1979Google Scholar
  19. 19.
    Niemegeers CJE:In vivo pharmacology of antidiarrhoeal agents.In Diarrhoea—New insights, NW Read (ed). Clinical Research Reviews, Vol 1, Suppl 1, 1982 (in press)Google Scholar
  20. 20.
    Jaffe JH, Kanzler M: Abuse potential of loperamide. Clin Pharmacol Ther 28:812–819, 1980PubMedGoogle Scholar
  21. 21.
    Cohen RA, Pops MA: Paradoxical diarrhea with opiates. J Am Med Assoc 205:802, 1968Google Scholar
  22. 22.
    Krejs GJ, Fordtran JS: The physiology and pathophysiology of ion and water movement in the human intestine.In Gastrointestinal Disease, MH Sleisenger, JS Fordtran (eds). Philadelphia, WB Saunders & Co. 1978, pp 313–335.Google Scholar

Copyright information

© Digestive Disease Systems, Inc. 1982

Authors and Affiliations

  • Maria Read
    • 1
  • N. W. Read
    • 1
  • D. C. Barber
    • 1
  • H. L. Duthie
    • 1
  1. 1.Departments of Surgery, Medical Physics and PhysiologyRoyal Hallamshire HospitalSheffieldEngland

Personalised recommendations